Form 4: Elanco Animal Health Director William F. Doyle Receives Stock Award

Director William F. Doyle of Elanco Animal Health Inc. received 18,169 shares of common stock as part of an annual equity award.

Summary

• William F. Doyle, a director at Elanco Animal Health Inc., received 18,169 shares of common stock on November 29, 2024.
• These shares were granted as part of an annual equity award to non-employee members of the Board of Directors.
• Following this transaction, Mr. Doyle's total holdings decreased to 94,499 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, a standard equity grant to a board member, which is generally viewed neutrally to slightly positive as it aligns interests.

Positives

• The grant of stock units aligns the interests of non-employee directors with those of shareholders.
• The equity award is part of a standard compensation practice for board members.

Industry Context

This type of equity award is a common practice for compensating non-employee directors in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Equity grants to non-employee directors are a standard practice across publicly traded companies.
• The size of the grant is likely determined by the company's compensation policies and the director's role.
• Companies like Zoetis and IDEXX Laboratories also use similar equity-based compensation for their board members.

Stakeholder Impact

• The stock grant aligns the interests of the director with those of shareholders.
• The transaction has a minor impact on the overall share structure of the company.

Key Dates

Keywords

Elanco Animal Health, Director, Stock Award, Equity Grant, Beneficial Ownership, Form 4, William F. Doyle